Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030717 |
---|---|
Receipt number | R000035070 |
Scientific Title | The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer. |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2019/10/04 17:00:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/01/07 12:58:03 | ||
2 | Update | 2018/07/12 22:11:14 | Anticipated trial start date |
|
3 | Update | 2019/10/04 17:00:36 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |